TABLE I.
Patient Demographics
| Demographic or medical item | n(%) of 276 |
|---|---|
| Gender | |
| Female | 144 (52) |
| Age | |
| ≥18 | 235 (85) |
| Race | |
| Caucasian | 148 (55) |
| Asian | 112 (41) |
| Other | 11 (4) |
| Chelator type | |
| Deferoxamine | 65 (24) |
| Oral chelator | 153 (55) |
| Combination | 37 (13) |
| None | 21 (8) |
| Thalassemia diagnosis | |
| B-thal regularly transfuseda | 213 (78) |
| B-thal intermittently transfusedb | 24 (9) |
| B-thal nontransfusedc | 3 (1) |
| HbH CS | 4 (1) |
| E-B-thal regularly transfuseda | 22 (8) |
| E-B-thal intermittently transfusedb | 6 (2) |
| E-B-thal nontransfusedc | 1 (0.36) |
| Alpha-thal | 2 (0.73) |
| Ferritin | M ± SD, Median (range) 2,220 ± 2,530, 1,387 (67–23,712) |
| Country | |
| United States | 201 (73) |
| Canada | 36 (13) |
| United Kingdom | 39 (14) |
a
At least eight transfusions in past year
b
One to seven transfusions in past year
c
No transfusions in past year in past year.